Patents Assigned to Shire Pharmaceutical Development Inc.
  • Methods for the treatment of bipolar disorder using carbamazepine
    Patent number: 6977253
    Abstract: Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments until clinical efficacy is achieved.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: December 20, 2005
    Assignee: Shire Pharmaceutical Development Inc.
    Inventors: Amir H. Kalali, Simon J. Tulloch